共 8 条
[1]
Efficacy and variability of the antiproteinuric effect of ACE inhibition byclisinopril. Heeg JE,De Jong PE,Van der Hem GK deZeeaw D. Kidney International . 1989
[2]
Definition of the effective dose ofthe converting enzyme inhibitor benazepril. Whalen JJ. American Heart Journal . 1989
[3]
Crossuredesign for the close dcter mination of ananginotensin-converting eneryme inhibiter hypertension. Guyne TT,Bellet M,Sassano P,et al. Journal of Hypertension . 1989
[4]
Reduction of proteinuria by angi-stensin-Converting enzyme inhibition. Heag JE,De Jong PE,Van der Hem GK,et al. Kidney International . 1987
[5]
Converting enzyme inhibition and progressive glomerulosclerosis in the rat. Beavers JJB,Van der Wal A,Hoedemaeker PJ,et al. Kidney International . 1987
[6]
Control of hypertenson with angiotensin-convertinganzyime inhibitor captopril reduces glomeralarproteinuria. Ruilope LM,Mirarda B,Oliet A,et al. Journal of Hypertension . 1988
[7]
Theantihypertensive effects of benazepril non-sul-phydryl angiotensin-converting engyme inhititor, in patients with essential hypertension. Maggola C,Lissoni F,Scarpagga P,et al. Current Therapeutic Research . 1989
[8]
Converting enzyme inhibit and kidney function innormotensive diabetic patients with persistentproteinuria. Marre M,Leblanc H,Suareg L,et al. British Medical Journal . 1987